Carregant...
Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala
Amphetamine use is associated with dysphoric states, including heightened anxiety, that emerge within 24 h of withdrawal from the drug. Corticotropin-releasing factor increases serotonin release in the central nucleus of the amygdala, and this neurochemical circuitry may play a role in mediating fea...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2923226/ https://ncbi.nlm.nih.gov/pubmed/20655906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2010.07.008 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|